Financial sources for biotechnology companies in Germany 2005 to 2022
In 2022, biotechnology companies in Germany received around 475 million euros from risk capital. Since 2011 the amount of money invested in biotechnology companies has rapidly increased. 2020 and 2021 were by far the most successful years for funding.